ResearchReal-world clinical and economic burden of immunoglobulin-G4-related disease in the United States: A retrospective claims-based analysis
ResearchDifferences in SARS-CoV-2 Antigen Persistence in Individuals With Systemic Autoimmune Rheumatic Diseases Compared to the General Population: A RECOVER-Adult Cohort Study
ResearchBroad screening of inflammation-associated proteins identifies serum CCL19 as a novel biomarker of disease activity in IgG4-related disease
ResearchCOVID-19 Real World Data Infrastructure: A Big-Data Resource for Study of the Impact of COVID-19 in Immunocompromising Conditions
ResearchThe National Academies' 2024 Diagnostic Criteria for Long COVID: Concerns That Could Affect the Rheumatology Community
ResearchPatients with systemic autoimmune rheumatic diseases remain at risk for hospitalisation for COVID-19 infection in the Omicron era (2022–2024): a retrospective cohort study
ResearchSeverity of acute SARS-CoV-2 infection and risk of new-onset autoimmune disease: A RECOVER initiative study in nationwide U.S. cohorts
ResearchBurden of Metabolic Bone Disease in Patients with Immunoglobulin G4-Related Disease With and Without Autoimmune Pancreatitis: A Cross-Sectional Study
ResearchOutcomes of respiratory syncytial virus infection in patients with systemic autoimmune rheumatic disease
ResearchProspective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial
ResearchIdentification of an ANCA-Associated Vasculitis Cohort Using Deep Learning and Electronic Health Records